Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Relaxin 3 ELISA Kit (AC3549)
Cat.#: ASET-2138
Specifications
Description Rat Relaxin 3 ELISA Kit allows for the in vitro quantitative determination of rat Relaxin 3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2190 Human KIAA1199 ELISA Kit (AC3601) Quantitative inquiry ASET-2123 Human CD147 ELISA Kit (AC3534) Quantitative inquiry ASET-1254 Human SHP2 ELISA Kit (AC2665) Quantitative inquiry ASET-2405 Human Neuritin ELISA Kit (AC3816) Quantitative inquiry ASET-2301 Human Granulin ELISA Kit (AC3712) Quantitative inquiry ASET-1406 Human Ferritin Light Chain ELISA Kit (AC2817) Quantitative inquiry ASET-1291 Human beta Nerve Growth Factor ELISA Kit (AC2702) Quantitative inquiry ASET-1673 Mouse NKCC1 ELISA Kit (AC3084) Quantitative inquiry ASET-1156 Human PER2 ELISA Kit (AC2567) Quantitative inquiry ASET-1449 Mouse TrkB ELISA Kit (AC2860) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket